Follow on Google News News By Tag * Erosion * Generic * Therapy * Resistors * Drug * Setting * Pharmaceutical * Retail * Hospital * Oral * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | Now Available: Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent ExpiryNew Pharmaceuticals market report from Datamonitor: "Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry"
Pharma is facing slowing sales growth in the developed pharmaceutical markets, driven by increasing generic competition. However, the speed and severity of brand erosion is by no means equal across countries, prescribing setting, therapy area and formulation type; factors which are of key importance when managing and forecasting branded drug sales. Features and benefits * Analyzes brand erosion (in terms of volume and value) in the US, Japan, France, Germany, Italy, Spain, UK, Australia China and Russia * Assesses brand erosion across the two major prescribing settings (retail and hospital) * Examines brand erosion across the various different therapy areas * Analyzes brand erosion according to drug formulation (oral, oral long lasting, parenteral and other formulation types) ------------------------------------------------------------ Full Report Details at - http://www.fastmr.com/ ------------------------------------------------------------ Highlights Brands tended not to experience generic erosion in China following patent expiry since they often face generic competition from the outset, and instead continue to grow both in terms of volume and value. Brand erosion was greater in terms of speed and severity in the hospital setting most likely reflecting the greater brand loyalty among patients in the retail setting. In terms of erosion by therapy areas, sales and volume erosion was the greatest among infectious disease, oncology, and cardiovascular small molecule brands. Your key questions answered * Evaluate the evolving prescription pharmaceutical landscape and how this is being impacted by generics * Quantify sales and volume erosion across 10 major pharmaceutical markets according to prescribing setting, therapy areas, and drug formulation * Assess drivers and resistors for the uptake of generic drugs in each market Report Table of Contents: Executive Summary Introduction Strategic Scoping and Focus Key Findings Brand erosion by country Brand erosion by prescribing setting (retail versus hospital) Brand erosion by therapy area Brand erosion by formulation Overview of drugs analyzed Related Reports Upcoming related reports 2. BRAND EROSION ACROSS THE WORLD'S MAJOR MARKETS Overview of brand erosion across the world's major markets 3. GENERICS MARKET DYNAMICS Comparison of generic penetration across major pharmaceutical markets Generics volume uptake Generics value uptake Generics market size 4. GENERICS DRIVERS AND RESISTORS Overview of Generics Drivers and Resistors US - Generics drivers and resistors Japan - Generics drivers and resistors France - Generics drivers and resistors Germany - Generics drivers and resistors Italy - Generics drivers and resistors Spain - Generics drivers and resistors UK - Generics drivers and resistors China - Generics drivers and resistors Brazil - Generics drivers and resistors India - Generics drivers and resistors Russia - Generics drivers and resistors Australia - Generics drivers and resistors 5. BRAND EROSION IN THE RETAIL AND HOSPITAL SETTING Overview of brand erosion in the retail and hospital setting Retail and hospital erosion by country 6. BRAND EROSION BY THERAPY AREA Overview of brand erosion by therapy area Brand erosion by therapy area - Infectious diseases Brand erosion by therapy area - Cardiovascular Brand erosion by therapy area - Oncology Brand erosion by therapy area - Central Nervous System Brand erosion by therapy area - Respiratory Brand erosion by therapy area - Metabolic disorders Brand erosion by therapy area - Immunology and inflammation Brand erosion by therapy area - Other 7. BRAND EROSION BY DRUG FORMULATION Overview of brand erosion by drug formulation Brand erosion by drug formulation - Oral Brand erosion by drug formulation - Oral long lasting Brand erosion by drug formulation - Parenteral Brand erosion by drug formulation - Other formulations 8. BIBLIOGRAPHY Publications and online articles Datamonitor reports and products APPENDIX Exchange rates used in this report Brand erosion - methodology Datamonitor prescription pharmaceutical definition and therapy area classification About Datamonitor The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment. View more research from Datamonitor at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number